US Map / Montana
State MT

Clinical Trials in Montana

Montana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Montana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 40 actively recruiting studies with Montana sites out of 40 registered in total. The busiest research areas in Montana are Stage IVB Prostate Cancer AJCC v8, Vestibular Hypofunction, Intracranial Meningioma. Leading sponsors running trials in the state include Alliance for Clinical Trials in Oncology, SWOG Cancer Research Network, National Cancer Institute (NCI). By stage, Montana trials break down as Phase 2 (11), Phase 3 (21).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
40
Recruiting Now
40
← Back to US Map
Top Conditions in Montana
Stage IVB Prostate Cancer AJCC v8 (2)Vestibular Hypofunction (2)Intracranial Meningioma (2)Lung Non-Small Cell Carcinoma (2)Aging (1)HPV (1)HPV - Anogenital Human Papilloma Virus Infection (1)Metastatic Castration-Resistant Prostate Carcinoma (1)Metastatic Prostate Adenocarcinoma (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Estrogen Receptor Positive (1)HER2/Neu Negative (1)

Frequently Asked Questions — Clinical Trials in Montana

How many clinical trials are currently recruiting in Montana?
ClinicalMetric currently tracks 40 actively recruiting clinical trials with at least one location in Montana. The total number of registered studies—including active but not currently enrolling trials—is 40. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Montana?
Montana hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Vestibular Hypofunction, Intracranial Meningioma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Montana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Montana?
To join a clinical trial in Montana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Montana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Montana

NCT05720507 N/A
Recruiting
Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty
Condition
Aging
Enrollment
36 pts
Location
United States
Sponsor
University of Montana
View Trial →
NCT07758140 N/A
Recruiting
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
Condition
HPV
Enrollment
260 pts
Location
United States
Sponsor
Mel Mont Medical
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT07160244 Phase 3
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregn...
Condition
Healthy
Enrollment
6,000 pts
Location
United States, Argentina, Brazil
Sponsor
Pfizer
View Trial →
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,000 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
NCT05624996 Phase 3
Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for...
Condition
Locally Advanced Lung Non-Small Cell Carcinoma
Enrollment
474 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT07477704 Phase 2
Recruiting
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult P...
Condition
Hypercholesterolemia
Enrollment
420 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05899608 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
1,600 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT04871542 N/A
Recruiting
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Condition
Malignant Solid Neoplasm
Enrollment
2,062 pts
Location
United States, Chile, Guam
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05391932 N/A
Recruiting
Making INformed Decisions in Gaze and Postural Stability: A Pilot Feasibility St...
Condition
Vestibular Hypofunction
Enrollment
36 pts
Location
United States
Sponsor
University of Montana
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06998940 Phase 3
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Adva...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
94 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT07091617 N/A
Recruiting
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing ...
Condition
Miscellaneous Neoplasm, Nos
Enrollment
535 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06960759 Phase 2
Recruiting
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chro...
Condition
Chronic Cough (CC)
Enrollment
135 pts
Location
United States
Sponsor
University of Montana
View Trial →
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05486546 N/A
Recruiting
Contoura With Phorcides Compared to Wavefront Optimized LASIK
Condition
Myopia
Enrollment
120 pts
Location
United States
Sponsor
Daniel Terveen
View Trial →
NCT05677490 Phase 3
Recruiting
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanc...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
382 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04239573 N/A
Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Assoc...
Condition
Pancreatic Neoplasm
Enrollment
770 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07018869 Phase 3
Recruiting
Evaluating Whether an Educational Website Called Current Together After Cancer (...
Condition
Colorectal Cancer Stage II
Enrollment
1,057 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06317649 Phase 2
Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute M...
Condition
Acute Myeloid Leukemia
Enrollment
147 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07784725 Phase 3
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Over...
Condition
Obesity or Overweight
Enrollment
2,500 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
View Trial →
Page 1 of 2 — 40 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology